Thermo Fisher’s Oncomine Dx Test Is First FDA Approved NGS-Based Companion Diagnostic To Detect Thyroid Cancers
The FDA approved Thermo Fisher Scientific Inc’s (NYSE:TMO) Oncomine Dx Target Test as a companion diagnostic (CDx) to select patients with RET-fusion…